Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Normal Cells Sequester Telomerase But Cancer Cells Do Not

By Biotechdaily staff writers
Posted on 17 Sep 2002
Researchers have found that while the telomerase enzyme complex that maintains the telomeres capping each chromosome is sequestered within the nucleolus during most of the cell cycle and released into the nucleus only just before cell division, telomerase is not sequestered in constantly reproducing tumor cells and continually interacts with the chromosomes. More...
These findings were reported in the August 17, 2002, online edition of Nature Cell Biology.

During most of the cell cycle of cultured human fibroblasts, telomerase is attached to the outer region of the nucleolus, based on localization studies of the telomerase reverse transcriptase protein tagged with green fluorescent protein. However, just before cell division, when one would expect telomerase to be active at the telomeres, it suddenly appears throughout the nucleus.

Cancer cells, on the other hand, have evolved a mechanism to mobilize telomerase continually so they can maintain continual cell division while keeping the telomeres intact. The study's senior author, Dr. Kathleen Collins from the department of molecular and cell biology at the University of California, Berkeley (USA), explained, "Normal somatic cells keep most of the telomerase away from the DNA, whereas cancer cells let all of it go. This should help the transformed (cancer) cells use telomerase much more efficiently.”

A related finding was that cells exposed to ionizing radiation immediately sequester telomerase. This prevents the enzyme from adding telomere caps to exposed bits of DNA, which would hamper the cell's efforts to repair the damage.



Related Links:
University of California, Berkeley

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.